Histogen Inc.
HSTODelisted Oct 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001383701
Histogen Inc. was delisted on Oct 12, 2023; its insiders filed their last Form 4 on Jun 21, 2023; 9 institutions reported holding it in 13F filings for Q3 2023, worth $9.53K in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Histogen Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 10 | 13 | +3 |
| Shares | 100.6K | 129.1K | +28.5K (+28.3%) |
| Value | $229.0K | $174.0K | −$55.0K (−24.0%) |
New holders (6)
Institutions that held Histogen Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 27,227 | $37.0K | 0.00% |
| Two Sigma Securities, LLC | 10,921 | $15.0K | 0.00% |
| UBS Group AG | 5,318 | $7.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 4,256 | $6.00K | 0.00% |
| Morgan Stanley | 2,575 | $3.00K | 0.00% |
| Compagnie Lombard Odier SCmA | 15 | $0 | 0.00% |
Sold out (3)
Institutions that held Histogen Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| HRT Financial LP | 11,356 | $26.0K |
| Citadel Advisors LLC | 10,551 | $24.0K |
| JPMorgan Chase & Co | 5,571 | $13.0K |